Biblio
Export 25 results:
Author Title Type [ Year] Filters: Author is Soininen, Hilkka [Clear All Filters]
,
“High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms1.”, J Alzheimers Dis, vol. 52, no. 2, pp. 497-507, 2016.
, “Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1105-14, 2016.
, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
, “Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1077-1085, 2017.
, “Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1387-1395, 2017.
, “Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 809-817, 2017.
, “Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.”, J Alzheimers Dis, vol. 59, no. 2, pp. 695-705, 2017.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “Development of a Late-Life Dementia Prediction Index with Supervised Machine Learning in the Population-Based CAIDE Study.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1055-1067, 2017.
, “Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.”, J Alzheimers Dis, vol. 55, no. 3, pp. 995-1003, 2017.
, “Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 453-458, 2017.
, “Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.”, J Alzheimers Dis, vol. 56, no. 2, pp. 543-555, 2017.
, “The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1241-1251, 2017.
, “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
, “No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
, “Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial.”, J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
, “Interrelationship between the Levels of C9orf72 and Amyloid-β Protein Precursor and Amyloid-β in Human Cells and Brain Samples.”, J Alzheimers Dis, vol. 62, no. 1, pp. 269-278, 2018.
, “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change.”, J Alzheimers Dis, vol. 71, no. 3, pp. 785-795, 2019.
, “Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1243-1248, 2020.
, “Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 1, pp. 277-286, 2020.
,